🇺🇸 FDA
Patent

US 12049486

PAC1 receptor agonists (MAXCAPs) and uses thereof

granted A61KA61K31/4985A61K38/00

Quick answer

US patent 12049486 (PAC1 receptor agonists (MAXCAPs) and uses thereof) held by The United States Government represented by the Department of Veterans Affairs expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States Government represented by the Department of Veterans Affairs
Grant date
Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/4985, A61K38/00, A61K38/2278, A61K47/60